nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of Nonlinear and Nonsteady State Hepatic Extraction with the Dispersion Model Using the Finite Difference Method
|
Hisaka, Akihiro |
|
1998 |
|
5 |
p. 495-519 |
artikel |
2 |
Analysis of Nonlinear and Nonsteady State Hepatic Extraction with the Dispersion Model Using the Finite Difference Method
|
Akihiro Hisaka |
|
1998 |
|
5 |
p. 495-519 25 p. |
artikel |
3 |
Announcements
|
|
|
1999 |
|
5 |
p. 555-556 2 p. |
artikel |
4 |
Announcements
|
|
|
1999 |
|
5 |
p. 555-556 |
artikel |
5 |
Announcements
|
|
|
1997 |
|
5 |
p. 643-644 |
artikel |
6 |
Announcements
|
|
|
1997 |
|
5 |
p. 643-644 2 p. |
artikel |
7 |
A Parametric Confidence Interval for a Moment-Based Scaled Criterion for Individual Bioequivalence
|
Kimanani, Ebi K. |
|
1997 |
|
5 |
p. 595-614 |
artikel |
8 |
A Parametric Confidence Interval for a Moment-Based Scaled Criterion for Individual Bioequivalence
|
Ebi K. Kimanani |
|
1997 |
|
5 |
p. 595-614 20 p. |
artikel |
9 |
A Semiparametric Method for Describing Noisy Population Pharmacokinetic Data
|
Park, Kyungsoo |
|
1997 |
|
5 |
p. 615-642 |
artikel |
10 |
A Semiparametric Method for Describing Noisy Population Pharmacokinetic Data
|
Kyungsoo Park |
|
1997 |
|
5 |
p. 615-642 28 p. |
artikel |
11 |
Assuming Peripheral Elimination: Its Impact on the Estimation of Pharmacokinetic Parameters of Muscle Relaxants
|
Laurin, Julie |
|
1999 |
|
5 |
p. 491-512 |
artikel |
12 |
Assuming Peripheral Elimination Its Impact on the Estimation of Pharmacokinetic Parameters of Muscle Relaxants
|
Julie Laurin |
|
1999 |
|
5 |
p. 491-512 22 p. |
artikel |
13 |
A Tracer Interaction Method for Nonlinear Pharmacokinetics Analysis: Application to Evaluation of Nonlinear Elimination
|
Veng-Pedersen, P. |
|
1997 |
|
5 |
p. 569-593 |
artikel |
14 |
A Tracer Interaction Method for Nonlinear Pharmacokinetics Analysis Application to Evaluation of Nonlinear Elimination
|
P. Veng-Pedersen |
|
1997 |
|
5 |
p. 569-593 25 p. |
artikel |
15 |
Basic Pharmacodynamic Models for Agents That Alter Production of Natural Cells
|
Krzyzanski, Wojciech |
|
1999 |
|
5 |
p. 467-489 |
artikel |
16 |
Basic Pharmacodynamic Models for Agents That Alter Production of Natural Cells
|
Wojciech Krzyzanski |
|
1999 |
|
5 |
p. 467-489 23 p. |
artikel |
17 |
Construction of a Whole Body Blood Flow Model for Use in Positron Emission Tomography Imaging with [15O]Water
|
Narayana, Shalini |
|
1997 |
|
5 |
p. 539-568 |
artikel |
18 |
Construction of a Whole Body Blood Flow Model for Use in Positron Emission Tomography Imaging with 15OWater
|
Shalini Narayana |
|
1997 |
|
5 |
p. 539-568 30 p. |
artikel |
19 |
Course: Critical Issue in Tumor Microcirculation, Angiogenesis, and Metastasis: Biological Significane and Clinical Relevance
|
|
|
1998 |
|
5 |
p. 617-618 |
artikel |
20 |
Course Critical Issue in Tumor Microcirculation, Angiogenesis, and Metastasis Biological Significane and Clinical Relevance
|
|
|
1998 |
|
5 |
p. 617-618 2 p. |
artikel |
21 |
DrugDrug Pharmacodynamic Interaction Detection by a Nonparametric Population Approach. Influence of Design and of Interindividual Variability
|
Yann Merlé |
|
1999 |
|
5 |
p. 531-554 24 p. |
artikel |
22 |
Drug–Drug Pharmacodynamic Interaction Detection by a Nonparametric Population Approach. Influence of Design and of Interindividual Variability
|
Merlé, Yann |
|
1999 |
|
5 |
p. 531-554 |
artikel |
23 |
Estimating Potency for the Emax-Model Without Attaining Maximal Effects
|
Schoemaker, Rik C. |
|
1998 |
|
5 |
p. 581-593 |
artikel |
24 |
Estimating Potency for the Emax-Model Without Attaining Maximal Effects
|
Rik C. Schoemaker |
|
1998 |
|
5 |
p. 581-593 13 p. |
artikel |
25 |
Indirect-Response Modeling of Desmopressin at Different Levels of Hydration
|
Callréus, Torbjörn |
|
1999 |
|
5 |
p. 513-529 |
artikel |
26 |
Indirect-Response Modeling of Desmopressin at Different Levels of Hydration
|
Torbjörn Callréus |
|
1999 |
|
5 |
p. 513-529 17 p. |
artikel |
27 |
Integrated Pharmacokinetic–Pharmacodynamic Model for Acetaminophen, Ibuprofen, and Placebo Antipyresis in Children
|
Brown, R. Don |
|
1998 |
|
5 |
p. 559-579 |
artikel |
28 |
Optimal Experimental Design for Precise Estimation of the Parameters of the Axial Dispersion Model of Hepatic Elimination
|
Chou, Chen-Hsi |
|
1998 |
|
5 |
p. 595-615 |
artikel |
29 |
Optimal Experimental Design for Precise Estimation of the Parameters of the Axial Dispersion Model of Hepatic Elimination
|
Chen-Hsi Chou |
|
1998 |
|
5 |
p. 595-615 21 p. |
artikel |
30 |
PharmacokineticPharmacodynamic Modeling of Tolmetin Antinociceptive Effect in the Rat Using an Indirect Response Model A Population Approach
|
Francisco J. Flores-Murrieta |
|
1998 |
|
5 |
p. 547-557 11 p. |
artikel |
31 |
Pharmacokinetic–Pharmacodynamic Modeling of Tolmetin Antinociceptive Effect in the Rat Using an Indirect Response Model: A Population Approach
|
Flores-Murrieta, Francisco J. |
|
1998 |
|
5 |
p. 547-557 |
artikel |
32 |
Quantitative Structure–Pharmacokinetics Relationships: II. A Mechanistically Based Model to Evaluate the Relationship Between Tissue Distribution Parameters and Compound Lipophilicity
|
Nestorov, Ivan |
|
1998 |
|
5 |
p. 521-545 |
artikel |
33 |
Quantitative StructurePharmacokinetics Relationships II. A Mechanistically Based Model to Evaluate the Relationship Between Tissue Distribution Parameters and Compound Lipophilicity
|
Ivan Nestorov |
|
1998 |
|
5 |
p. 521-545 25 p. |
artikel |